S. GÜR Et Al. , "Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets," UROLOGY , vol.82, no.3, 2013
GÜR, S. Et Al. 2013. Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets. UROLOGY , vol.82, no.3 .
GÜR, S., Sikka, S. C., Abdel-Mageed, A. B., Abd Elmageed, Z. Y., Rezk, B., Pankey, E., ... Kadowitz, P. J.(2013). Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets. UROLOGY , vol.82, no.3.
GÜR, SERAP Et Al. "Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets," UROLOGY , vol.82, no.3, 2013
GÜR, SERAP Et Al. "Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets." UROLOGY , vol.82, no.3, 2013
GÜR, S. Et Al. (2013) . "Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets." UROLOGY , vol.82, no.3.
@article{article, author={SERAP GÜR Et Al. }, title={Imatinib Mesylate (Gleevec) Induces Human Corpus Cavernosum Relaxation by Inhibiting Receptor Tyrosine Kinases (RTKs): Identification of New RTK Targets}, journal={UROLOGY}, year=2013}